Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part, have agreed by signing a consent form, and are able to follow the study requirements
- You have been diagnosed with a type of lung cancer called non-small-cell lung cancer (NSCLC) that is advanced or has spread, confirmed by a lab test, and you have not received any treatment for it yet
- You do not have certain genetic changes (called "driver gene mutations") in your cancer
- You are willing to receive immunotherapy on its own or combined with chemotherapy
- You are willing to provide a leftover tissue sample (from your routine diagnosis) so it can be tested as part of this study
- Your general health and ability to carry out daily activities is rated as good (a score of 0 or 1 on a standard medical scale — confirm with trial site)
- You have at least one area of cancer that can be measured or assessed on scans
Who may not be able to join:
- You do not meet the standard medical requirements for receiving usual cancer treatment, based on your doctor's assessment
- Your cancer has specific genetic changes known as EGFR mutations, ALK rearrangements, or ROS1 rearrangements
- The study doctor believes, for any reason, that this study would not be appropriate for you (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Wangjun Liao, MD, PhD, Nanfang Hospital, Southern Medical University
Phone: 86-20-62787731
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective Response Rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.